ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 100 participants.

Also called NCT05686317

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05686317
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Brazil, Canada, Germany, Switzerland (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05686317. Randomized; double masking; primary purpose treatment. Start 2023-04-01 (actual); primary completion 2026-11-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System
Acronym
ALT-FLOW II
Condition
Heart Failure
Intervention (Device)
Edwards APTURE transcatheter shunt system
Intervention (Diagnostic test)
Sham procedure
Lead sponsor
Edwards Lifesciences (class: industry)

Record details

Record id
cardio:ct-nct05686317
Content hash
f4717d11ed9d8b0f2257be4de100e9a199a9c49e01288063d6bd1f9905c2d63b